HHS Memo Stokes Concerns About Political Interference At FDA

By Beth Wang / September 21, 2020 at 3:23 PM
HHS on Sunday evening (Sept. 20) defended a new internal policy that requires HHS Secretary Alex Azar to formally sign off on any health agency rules, including those from FDA, saying that it’s intended to minimize litigation risks. But former FDA chief Scott Gottlieb says the memo comes at the wrong time, and will only add to concerns that FDA is being “bullied” by the Trump administration. In its Sunday statement , the health department maintains that the new procedure...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.